Four novel mutations in deficiency of coagulation factor XIII: Consequences to expression and structure of the A-subunit

Blood

Volumn 87, Issue 1, 1996, Pages 141-151

  Mikkola, Hanna ^b   Yee, Vivien C ^b   Syrjälä, Martti ^b   Seitz, Rainer ^b   Egbring, Rudolf ^b   Petrini, Pia ^b   Ljung, Rolf ^b   Ingerslev, Jorgen ^b   Teller, David C ^b   Peltonen, Leena ^b   Palotie, Aarno ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 13A; GLUTAMINE; ISOLEUCINE; LEUCINE; MESSENGER RNA; METHIONINE; PROLINE;

ADOLESCENT; ADULT; ALPHA CHAIN; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CODON; DENMARK; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY STUDY; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENETIC ANALYSIS; GERMANY; HUMAN; HYDROGEN BOND; IMMUNOFLUORESCENCE; MALE; MISSENSE MUTATION; MUTATION; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWEDEN;

EID: 13344261413     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.141.141     Document Type: Article

References (47)

1. Duckert F: Documentation of the plasma factor XIII deficiency in man. Ann N Y Acad Sci 202:190, 1972
2. Miloszewski KJA, Losowsky MS: Fibrin stabilization and factor XIII deficiency, in Horwood E (ed): Fibrinogen, Fibrin Stabilization and Fibrinolysis, Chichester, UK, L. Francis, 1988, p 175
3. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5:3071, 1991
4. Aeschlimann D, Paulsson M: Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 71:402, 1994
5. Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SJP, Ponec M, Bom A, Lautenschlager S, Schorderet DF, Hohl D: Mutations of keratinocyte transglutaminase in lamellar ichtyosis. Science 267:525, 1995
6. Russel LJ, DiGiovanna JJ, Geraldine RR, Steinert PM, Hashem N, Compton J, Bale SJ: Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichtyosis. Nature Genetics 9:279, 1995
7. Sakata Y, Aoki N, Matsuda M, Tateno K: Crosslinking of α2-plasmin inhibitor to fibrin by fibrin stabilizing factor. J Clin Invest 65:290, 1980
8. Mosher DF, Johnson RB: Crosslinking of collagen and fibrin by factor XIII. J Biol Chem 255:1181, 1980
9. Mosher DF, Johnson RB: Specificity of fibronectin-fibrin crosslinking. Ann NY Acad Sci 255:1181, 1983
10. Schwartz ML, Pizzo SV, Hill RL, McKee PA: Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248: 1395, 1973
11. Mary A, Achyuthan KE, Greenberg CS: B-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. Biochim Biophys Acta 966:328, 1988
12. McDonagh J, McDonagh RP, Delage JM, Wagner RJ: Factor XIII in human plasma and platelets. J Clin Invest 48:940, 1969
13. Muszbek L, Adany R, Szegedi G, Polgar J, Kavai M: Factor XIII of blood coagulation in human monocytes. Thromb Res 37:401, 1985
14. Henriksson P, Becker S, Lynch G, McDonagh J: Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 76:528, 1985
15. Poon MC, Russell JA, Low S, Sinclair GD, Jones AR, Blahey W, Ruether BA, Hoar DI: Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. J Clin Invest 84:787, 1989
16. Lorand L, Jeong JM, Radek JT, Wilson J: Human plasma factor XIII: Subunit interactions and activation of zymogen. Methods Enzymol 222:22, 1993
17. Yee VC, Pedersen LC, le Trong I, Bishop PD, Stenkamp RE, Teller DC: Three-dimensional structure of a transglutaminase: Human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296, 1994
18. Pedersen LC, Yee VC, Bishop PD, le Trong I, Teller DC, Stenkamp RE: Transglutaminase factor XIII uses a proteinase-like catalytic triad to crosslink macromolecules. Protein Science 3:1131, 1994
19. Yee VC, Pedersen LC, Bishop PD, Stenkamp RE, Teller DC: Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res 78:389, 1995
20. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45, 1966
21. Egbring R, Schmidt W, Havemann K: Simplified radiologie factor XIII determination and its clinical use in congenital factor XIII deficiency (I). Blut 27:6, 1973
22. Fickenscher K, Aab A, Stuber W: A photometric assay for blood coagulation factor XIII. Thromb Haemost 65:535, 1991
23. Carlebjork G: A precise routine method for determination of FXIII activity in plasma. Thromb Res 21:507, 1981
24. Stenberg P, Stenflo J: A rapid and specific fluorescent activity staining procedure for transamidating enzymes. Anal Biochem 93:445, 1979
25. Josso F, Prou-Wartelle O, Alagille D, Soulier JP: Le deficit congenital en facteur stabilisant de la fibrine (facteur XIII). Etude de deux cas. Nouv Rev Fr Hematol 4:267, 1964
26. Egbring R, Andrassy K, Egli H, Meyer LJ: Two patients with congenital factor XIII deficiency. Contribution to the problem of factor XIII determination. Thromb Diath Haemorrh 23.313, 1970
27. Seiving B, Henriksson P, Stenberg P, Nilsson IM: A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency. Br J Haematol 82:414, 1992
28. Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, Palotie A: Deficiency in the A-subunit of coagulation factor XIII: Two novel point mutations demonstrate different effects on transcript levels. Blood 84:517, 1994
29. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766, 1989
30. Syvänen AC, Aalto-Setälä K, Kontula K, Söderlund H: Direct sequencing of affinity-captured amplified human DNA application to the detection of apolipoprotein E polymorphisms. FEBS Lett 258:71, 1989
31. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463, 1977
32. Syvänen AC, Aalto-Setäla K, Harju L, Kontula K, Söderlund H: A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 8:684, 1990
33. Brunger AT, Kuriyan J, Karplus M: Crystallographic R factor refinement by molecular dynamics. Science 235:458, 1987
34. Jones TA, Zou J-Y, Cowan SW, Kjelgaard M: Improved methods for building models in electron density maps and location of errors in these models. Acta Crystallogr A 47:110, 1991
35. Kraulis PJ: MOLSCRIPT, a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946, 1991
36. Hol WG, van Duijnen PT, Berendsen HJ: The alpha helix dipole and the properties of proteins. Nature 273:443, 1978
37. Standen GR, Bowen DJ: Factor XIII A Bristol 1: Detection of a nonsense mutation (Arg171 → stop codon) in factor XIII deficiency. Br J Haematol 85:769, 1993
38. Board PG, Losowsky MS, Miloszewski KJ: Factor XIII: Inherited and acquired deficiency. Blood Rev 7:229, 1993
39. Board P, Coggan M, Miloszewski K: Identification of a point mutation in factor XIII A subunit deficiency. Blood 80:937, 1992
40. Ichinose A, Kaetsu H: Molecular approach to structure-function relationship of human coagulation factor XIII. Methods Enzymol 222:36, 1993
41. Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y: Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5′ end of exon III. J Clin Invest 90:315, 1992
42. Cooper D: Human gene mutations affecting RNA processing and translation. Ann Med 25:11, 1993
43. Cheng J, Fogel PM, Maquat LE: Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol Cell Biol 10:5215, 1990
44. Urlaub G, Mitchell PJ, Ciudad CJ, Chasin LA: Nonsense mutations in the dihydrofolate reductase gene affect RNA processing Mol Cell Biol 9:2868, 1989
45. Lorand L, Urayama T, De Kiewiet JWC, Nossel HL: Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 48:1054, 1969
46. Henriksson P, McDonagh J, Villa M: Type I autoimmune inhibitor of factor XIII in a patient with congenital factor XIII deficiency. Thromb Haemost 50.272, 1983
47. Lorand L: Acquired inhibitors of fibrin stabilizing system: A class of haemorrhagic disorders of diverse origins, in Green D (ed): Anticoagulants: Physiologic, Pathologic, and Pharmacologic. Boca Raton, FL, CRC, 1994, p 169